Indeed, iron trafficking, by modifying energetic metabolism of cancer cells and impairing inflammatory status of macrophages, represents a critical regulator of myeloma cell-macrophage interactions, shaping the MM tumor niche and promoting BTZ-resistance. The gene discussed is CASC3; the disease is cancer.